Pioglitazone Tablet
Product Images NDC 68071-5245

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Pioglitazone (NDC 68071-5245). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 5245 3)

Packaging label for Pioglitazone 15 mg tablets by NuCare Pharmaceuticals, Inc. The label indicates a quantity of 30 tablets. The tablets are described as round white/off-white and debossed with 'TEVA' and '7271'. The label includes the NDC 68071-5245-3 and storage instructions to keep at controlled temperature 68-77°F. Manufactured by Teva Czech Industries, s.r.o., Teva Komarov, Czech Republic.*

FDA Label Image

Chemical Structure (Image 1)

Chemical structure of pioglitazone hydrochloride, showing the molecular arrangement of atoms including pyridine, benzene rings, and a thiazolidinedione moiety.*

FDA Label Image

Figure 1 (Image 2)

A line graph depicting mean values across weeks for four groups: placebo, 15 mg, 30 mg, and 45 mg dosages. The x-axis represents weeks from 0 to 26, and the y-axis shows mean values ranging from -2.0 to +0.7. Different colored lines and markers differentiate the groups, showing trends over time.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.